Jacqueline Mejia, PhD’s Post

That’s a wrap! Another exciting PharmStars Alumni Showcase for the books took place last week. PharmStars’ unique #DigitalHealth #accelerator doesn’t end for our startups after graduation from PharmaU. This event was yet another opportunity to engage our #pharma members, investors, press and fellow startup leaders. We thank all the attendees for joining us and for contributing - we’ve already heard about many follow-up conversations planned with our startups. Thanks to our pharma members who bring the hard questions and provide such encouraging support: Alexion Pharmaceuticals, Inc., AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Pfizer, and Sumitomo Pharma America, Inc. Thanks also to representatives from these investor groups. Their interest and input help fuel the startups’ activities and priorities: Fusion Fund, Hikma Ventures, Innospark Ventures, and Touchdown Ventures. And thanks to the members of the press who joined us to help spread the word about these rapidly advancing companies. What achievements and accomplishments did these #PharmStarsAlumni from our Fall 2022 Cohort “Digital #Innovations in Real World Evidence” report at our Showcase? ⭐Raising millions in capital in a tough funding environment ⭐Receipt of many awards, prizes, and recognition ⭐Strengthening, expanding and/or pivoting their digital health products ⭐Publication of scientific papers and case studies  ⭐Partnerships with providers and big tech firms ⭐⭐ Pharma deals galore! 9 with PharmStars members and 50 with other biopharma partners Stay tuned for another post with details on these PharmStars alumni startup milestones that were shared at the Showcase. If you want to become a PharmStars alumni or member, and participate in a future Showcase, check out www.Pharmstars.com for more information. Meredith Cohen Marcella Rogers Joanne Kamens, PhD #accelerator #innovation #DigitalHealth #startup #pharma #DigitalInnovation #healthcare #medtech #HealthIt #biopharma #oncology #entrepreneurship

The new partnership between Singapore Economic Development Board (EDB) and JLABS, Johnson & Johnson's incubator arm, sees greater support for local #biotech startups in terms of talent development and commercialisation opportunities.🤝 Read more to find out where #lifesciences fit in Singapore's broader #manufacturing ambitions, and what this partnership means for the life sciences ecosystem. Melinda Richter Wan Yee Goh Heng-Tong CHOO

𝐁𝐨𝐨𝐬𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐮𝐜𝐜𝐞𝐬𝐬 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐨𝐟 𝐩𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐒𝐭𝐚𝐫𝐭𝐮𝐩: 𝐭𝐡𝐞 𝐨𝟐𝐡 𝐤𝐢𝐜𝐤𝐬𝐭𝐚𝐫𝐭𝐞𝐫 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧 Biotech startups have a significant impact on the future of healthcare, agriculture, and other industries. They possess the key to creating transformational answers to some of the major global crises. However, the path to achievement is not without challenges. Financial limits, regulatory difficulties, fewer facilities for research centers, a lack of expertise, and tough competition frequently slow down the success of potential biotech startups. To assist with some of the above mentioned issues and to provide the necessary support to the USA-based early-stage biotech startups, o2h discovery launched the o2h kickstarter program 5.0 aims to provide significant assistance and support to these early-stage biotech startups in several ways, including a dedicated team of 6 chemists, Access to expertise, State-of-the-art Research Facilities, Inventory Access, etc. Read more - https://lnkd.in/grB3kMyc The 2nd edition of the Kickstarter competition for USA biotech startups is live now and applications are being accepted. If you are looking forward to give a boost to your drug discovery and development program, register your application at - kickstarter@o2h.com or visit - https://lnkd.in/dR8mbaPF #o2hkickstarter #seedingnewideas #o2hcollaborativeinnovation #unitedstates #nurturing #earlystage #biotech #lifescience #chemistryCRO #drugdiscovery #chemistry #research

🚀 Swiss MedTech and Biotech Companies Attract CHF 870 Million in Investments! 🌐💼 Switzerland's medtech and biotech sectors continue to thrive, with a staggering CHF 870 million in recent investments. This influx of capital underscores the robust growth and innovation happening in the Swiss life sciences landscape. 🇨🇭💡 Investors are recognizing the potential of Swiss companies in driving advancements in healthcare and biotechnology. 📈✨ #MedTech #BioTech #InnovationImpact #Switzerland BioAlps - Life Sciences Cluster 🇨🇭 Recrutis Swiss International Venture Capital Ltd. Distalmotion Lunaphore seca – precision for health Nice article from BioAlps - Life Sciences Cluster 🇨🇭 :

PharmStars is the go-to #accelerator for startups looking to engage #pharma as clients. “PharmStars was one of the best and most practically useful of all the accelerators we've participated in,” said #PharmStarsAlumni, Nader Alaghband, CEO of Ampersand Health. Why? Because of our: 🎯 Personalized mentoring: Tailored guidance for your startup's success by a small team of former pharma executives (no big, volunteer network of mentors!) 🎯 Pharma curriculum: Comprehensive curriculum about how pharma works and how to engage them in deals 🎯 Pharma Fireside Chats: Hear from and ask questions of pharma champions from our members in an intimate setting 🎯 Showcase Event: In-person pitch presentation followed by private meetings with our pharma members PharmStars 🚀 is now accepting applications for our Fall 2024 cohort, focused on #startups with digital #innovations in #ClinicalTrials. 📢 📢 📢 Apply on our website www. PharmStars.com by July 15, 2024 #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #businessdevelopment #bizdev #engagement #financing #funding #biopharma #healthcare #digitaltransformation #digitalinnovation, #remotemonitoring #patientexperience #digital #innovation #virtualtrials #acceleratorprogram #datacollection #RemotePatientMonitoring #RPM #datamanagement #VC #clinicaltrials #digitalhealth #startup #pharmaceutical #biotech #HIT #medtech #healthtech #HealthIT

🔬 Unveiling the Biotech Frontier: Insights from Early-Stage Investing! 🔍 Embark on a journey through the dynamic world of biotech innovation with McKinsey's latest research. Gain valuable insights into the trends, challenges, and opportunities shaping the future of life sciences. 💊✨ 💡 Key Takeaways: - Exploring the landscape of early-stage investments in biotech. - Unraveling trends that define the future of healthcare innovation. - Understanding the strategies driving success in life science startups. 🚀 Join the Conversation ! How are early-stage investments shaping the biotech landscape in your view? Share your thoughts below! Read more about the fascinating intersection of science, technology, and investment: https://lnkd.in/eds-vuTK #BiotechInnovation #LifeSciences #Investing #Biotechnology #InnovationInsights #LifeScienceInvesting #HealthcareInnovation #BiotechTrends #InvestmentStrategies #ScienceAndTechnology #StartupEcosystem #BiotechStartups #McKinseyResearch #FutureOfHealthcare

Vol 8 -Newsletter of Investingintalent #startups #funding

Many great scientific ideas don't get commercialized.... Not for lack of trying or lack of commercial potential but often times because of where they originate. A lot of academic institutions, where a good share of new therapeutic ideas or strategies start, are not truly equipped to help commercialize these potential drugs. Not to the fault of the institutions as drug discovery is a very complicated, risky and resource intensive endeavor. I also believe it to be more nuanced then other common startup sectors. Other institutions have good ecosystems for supporting the launch of new ideas while others simply attract VC given their name or status. What about all those universities that don't get looked at by VCs or founders with experience? Often those same ones don't have a robust ecosystem for launching new ideas and companies. How do we create incentives to get more ideas out of those institutions? Going back to yesterday's post, can we combine them with ideas from institutions with strong ecosystems or funding to create more value while also elevating that otherwise overlooked science? I am fortunate to be in one of the best biotech / drug discovery ecosystems in the world in Boston but not everyone is. #Biotech #Biopharma #DrugDiscovery #VentureCapital #Boston #Startup

A great read from Nature Portfolio about co-working labs for #biotech #startups. The article explores how shared lab spaces enhance startup growth by fostering a sense of community, providing access to mentors and saving costs. STEMCELL Technologies #biotechinnovation #biotechrevolution #coworkinglabs #collaborativeresearch #labspace #startupcommunity #innovationinscience #startupsuccess

What lessons can we learn from #biotech entrepreneurs that apply across industries in this #VC funding winter? Takeaways (1) Facing challenging funding options, 48% are looking to partnerships with larger firms, (2) "Biopharma VC funds are expected to hit $24B—the lowest tally in four years" is a familiar story across industries (except for the "Ai" boom), (3) 60% of firms still expect to increase #researchanddevelopment spending over the next 2yrs, (4) Despite it all, financial confidence was still 94% (very + somewhat). Optimism. #Astrapreneurship is hard enough, so from time to time, its essential to look not just up to #space but across #deeptech to places like #biotech entrepreneurs for ideas. -GSP- MilkyWayEconomy The Space Economy